Brief: Immutep - To Focus Efti Development On Hnscc With Cps < 1 And Neoadjuvant Sts
11/09/2026 13:07
BRIEF-Immutep - To Focus Efti Development On Hnscc With Cps < 1 And Neoadjuvant Sts Sept 11 (Reuters) - Immutep Ltd IMM.AX:
IMMUTEP - TO FOCUS EFTI DEVELOPMENT ON HNSCC WITH CPS < 1 AND NEOADJUVANT STS
IMMUTEP - CONTRACTS NEW MANUFACTURING RUN OF EFTI AT 200 L SCALE
IMMUTEP - TARGETS NEXT EFTI CLINICAL TRIALS START IN 2H CY2027
Source text: ID:nGNXbCmhdj
Further company coverage: IMM.AX
((Reuters.Briefs@thomsonreuters.com;))